ExoCoBio

Seoul, South Korea · Founded 2017 · Privately Held (backing)

Developer of regenerative medicine and biopharmaceuticals designed to create value for the healthy life of mankind. ExoCoBio is based in Seoul, South Korea and was founded in 2017. Its last known valuation is $510,000. It has raised $55.3 million.

Last price · $/share
—
Implied valuation
$510K
Total raised
$55.3M
Last round
—
What is ExoCoBio worth?
$510Klast known valuation
Free account
More of ExoCoBio with a free account
  • ·The complete investor list: 20 names
  • ·Watch ExoCoBio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

ExoCoBio funding history

No rounds on record

No funding rounds for ExoCoBio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

ExoCoBio valuation

ExoCoBio's last known valuation is $510,000. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How ExoCoBio's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For ExoCoBio, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about ExoCoBio

What is ExoCoBio worth?
ExoCoBio's last known valuation is $510K.
How much has ExoCoBio raised?
ExoCoBio has raised $55.3M in total funding across its recorded rounds.